Asthma Allergy Immunology

Asthma Allergy Immunology

Patient-Reported Outcomes in Assessing Disease Activity, Control, and Quality of Life in Chronic Spontaneous Urticaria

Nazan BEYHAN 1, Murat TURK 2, Insu YILMAZ 2, Sevim BAVBEK 1,

1 Department of Chest Diseases, Division of Allergy and Clinical Immunology, Ankara University, Faculty of Medicine, Ankara, Türkiye
2 Department of Chest Diseases, Division of Allergy and Clinical Immunology, Erciyes University Faculty of Medicine, Kayseri, Türkiye

DOI: 10.21911/aai.2024.564
Viewed: 262
 - 
Downloaded : 382

Chronic spontaneous urticaria (CSU) is a heterogeneous disease that significantly affects patients` quality of life due to its unpredictable nature and discomforting symptoms. Due to the variable course of the disease, the current condition of the disease should be comprehensively evaluated at every visit by healthcare providers. However, objective and specific biomarkers are lacking. Information about disease activity, disease control and quality of life can only be obtained from patients` reports regarding their health status, symptoms, life quality, or improvements during treatment. To do that, using patient-reported outcomes (PROs) is crucial in assessing the effectiveness of treatments, making decisions about treatment changes, and evaluating the patient`s general well-being. This article will provide information about current validated PROs recommended by guidelines for evaluating CSU.

Keywords : Patient-reported outcomes, chronic spontaneous urticaria, disease activity, disease control, quality of life